Skip to content
★ Sign in to follow
JE

Jonas Ekblom

Promore Pharma ABPromore Pharma
Total declarations
7
Companies
2
▲ Purchases (7 ops.)
€15k
▼ Sales (0 ops.)
—

Latest filing published 01 Jul 2021 for Promore Pharma AB, €1,971.

Filing timeline

BuySale
Jonas Ekblom

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Jonas Ekblom: trading record in brief

Jonas Ekblom discloses dealings in 2 companies, chiefly Promore Pharma and Promore Pharma AB. We count 7 filings; the first trade dates from 18 October 2019 and the latest from 29 June 2021.

Every open-market trade on record is a purchase: 7 purchases worth €15k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2021, the count stands at 2 purchases and no sales.

In size, the median ticket on the buying side is €2,618. On 1 out of 5 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 1 July 2021: an open-market purchase of €1,971, in Promore Pharma AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 3 days. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Jonas Ekblom

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    Verkställande direktör (VD)ExecutivesPromore Pharma AB
    20,000 SEK0FI-SE
    10,000 shares@ SEK 2.0037.6% of flowBTA (betald tecknad aktie)ISIN SE0016074629FI:csv-1552a89045c0fa2b86e5
    Canonical exit: 27 Sept 2021 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPromore Pharma AB
    33,332 SEK0FI-SE
    16,666 shares@ SEK 2.0062.4% of flowBTA (betald tecknad aktie)ISIN SE0009947740FI:csv-096bc8e4b50d71b504fb
    Canonical exit: 15 Sept 2021 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPromore Pharma
    38,000 SEK38FI-SE
    10,000 shares@ SEK 3.8036.6% of flowAktieISIN SE0009947740FI:csv-87deec93cfb0a4c14cde
    Canonical exit: 24 Feb 2021 (T+90)
  • ▲
    VDExecutivesPromore Pharma
    27,621 SEK25FI-SE
    7,445 shares@ SEK 3.7125.6% of flowAktieISIN SE0009947740FI:csv-68ed390eb4dda3a88cb1
    Canonical exit: 26 Feb 2020 (T+90)
  • ▲
    Verkställande direktörExecutivesPromore Pharma
    500 SEK22FI-SE
    100 shares@ SEK 5.000.5% of flowAktieISIN SE0009947740FI:csv-811560ed269f85fc8e7a
    Canonical exit: 16 Jan 2020 (T+90)
  • ▲
    Verkställande direktörExecutivesPromore Pharma
    36,941 SEK25FI-SE
    6,655 shares@ SEK 5.550933.6% of flowAktieISIN SE0009947740FI:csv-3263bb20a6f3736be880
    Canonical exit: 19 Jan 2020 (T+90)
  • ▲
    Verkställande direktörExecutivesPromore Pharma
    4,160 SEK22FI-SE
    800 shares@ SEK 5.203.8% of flowAktieISIN SE0009947740FI:csv-5a60cb322851a4e90223
    Canonical exit: 16 Jan 2020 (T+90)

7 of 7 declarations